Enhertu

Daiichi Sankyo launches first DTC ad for Enhertu, representing shift toward patient-centric oncology campaigns
Medical Marketing and Media
Sun, 09/22/24 - 09:46 pm
Daiichi Sankyo
AstraZeneca
breast cancer
metastatic breast cancer
Enhertu
DTC ads
ESMO-2024: Enhertu to eclipse the standard of care in HER2+ breast cancer with brain metastases
Clinical Trials Arena
Tue, 09/17/24 - 11:20 am
ESMO
breast cancer
Daiichi Sankyo
Enhertu
metastatic breast cancer
clinical trials
EU starts review of Enhertu in HER2-ultra-low breast cancer
Pharmaphorum
Mon, 08/19/24 - 09:56 am
EMA
Europe
AstraZeneca
Daiichi Sankyo
breast cancer
Enhertu
After tense standoff, AstraZeneca and Daiichi's Enhertu turned away by NICE on pricing grounds
Fierce Pharma
Mon, 07/29/24 - 10:51 am
AstraZeneca
Daiichi Sankyo
Enhertu
NICE
UK
HER2-low breast cancer
Daiichi Sankyo Wins $47M in ADC Patent Arbitration With Seagen, Pfizer Dispute Looms
BioSpace
Mon, 07/1/24 - 11:14 am
Daiichi Sankyo
Seagen
patents
Enhertu
ASCO: AstraZeneca, Daiichi's Enhertu looks to make history again in HER2-ultralow breast cancer
Fierce Pharma
Sun, 06/2/24 - 02:46 pm
ASCO 2024
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
The Enhertu effect: Daiichi’s plan to build on the success of its crown jewel
Pharma Voice
Fri, 05/10/24 - 11:12 am
Daiichi Sankyo
Enhertu
oncology
Merck
AstraZeneca and Daiichi Sankyo’s Enhertu shows promise in breast cancer trial
Clinical Trials Arena
Mon, 04/29/24 - 11:12 am
AstraZeneca
Daiichi Sankyo
Enhertu
breast cancer
HER2-low breast cancer
FDA grants accelerated approval to Enhertu for metastatic HER2-positive cancers
Investing.com
Sun, 04/7/24 - 04:45 pm
AstraZeneca
Daiichi Sankyo
FDA
Enhertu
solid tumors
Surprise Enhertu rejection follows NICE process change
Pharmaphorum
Tue, 03/5/24 - 11:35 am
AstraZeneca
Daiichi Sankyo
HER2-low breast cancer
Enhertu
NICE
UK
6 first-half 2024 oncology data readouts to watch
BioSpace
Mon, 02/26/24 - 11:20 am
oncology
clinical trials
Daiichi Sankyo
AstraZeneca
Enhertu
metastatic breast cancer
Gilead Sciences
Trodelvy
bladder cancer
GSK
Zejula
Jemperli
ovarian cancer
Roche
tiragolumab
Tecentriq
non-small cell lung cancer
Cue Biopharma
CUE-101
head and neck cancer
Elicio Therapeutics
ELI-002
solid tumors
Daiichi Sankyo again dials up Enhertu sales forecast, advances 2nd AstraZeneca-partnered ADC
Fierce Pharma
Wed, 01/31/24 - 10:27 pm
Daiichi Sankyo
AstraZeneca
Enhertu
earnings
AstraZeneca, Daiichi aim for first pan-tumor ADC approval
BioPharma Dive
Mon, 01/29/24 - 11:25 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
pan-tumor
FDA
Seagen patent in Daiichi Sankyo ADC dispute nixed by USPTO News
Pharmaphorum
Wed, 01/17/24 - 09:38 am
Seagen
Daiichi Sankyo
patents
legal
Enhertu
USPTO
ESMO: AstraZeneca-Daiichi get clarity on patient deaths for Enhertu follow up Dato-DXd, survival data still unclear
Fierce Biotech
Mon, 10/23/23 - 05:22 pm
ESMO
Daiichi Sankyo
AstraZeneca
Enhertu
patient deaths
clinical trials
non-small cell lung cancer
Seagen wins future royalties in Enhertu patent dispute
Pharmaphorum
Wed, 10/18/23 - 10:07 am
Seagen
Daiichi Sankyo
breast cancer
Enhertu
drug royalties
Enhertu offers survival benefits in Phase II solid tumour trial
Clinical Trials Arena
Sat, 07/29/23 - 10:42 pm
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials
solid tumors
AstraZeneca stock slides as pivotal lung cancer readout on Daiichi-partnered ADC spooks investors
Fierce Biotech
Mon, 07/3/23 - 11:40 am
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
Enhertu
clinical trials
non-small cell lung cancer
AstraZeneca study points to new uses for targeted cancer drug Enhertu
BioPharma Dive
Mon, 06/5/23 - 11:32 am
ASCO 2023
AstraZeneca
Enhertu
uterine cancer
cervical cancer
ovarian cancer
bladder cancer
AstraZeneca, Daiichi Sankyo tease new Enhertu data — but details remain under wraps
Endpoints
Mon, 03/6/23 - 11:27 pm
AstraZeneca
Daiichi Sankyo
Enhertu
clinical trials

Pages